Nishizawa et al. (149) demonstrated that Bcl-6 is highly expressed in angioimmunoblastic T-cell lymphoma (AITL) and peripheral T-cell lymphomas (PTCL) containing tumor cells with Tfh features. Here, BCL6 is linked to neoplasm.